| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1985PNAS...82.6138S |
| P356 | DOI | 10.1073/PNAS.82.18.6138 |
| P932 | PMC publication ID | 391007 |
| P698 | PubMed publication ID | 2412230 |
| P5875 | ResearchGate publication ID | 20744339 |
| P2093 | author name string | J Kenney | |
| A B Schreiber | |||
| R Friesel | |||
| T Maciag | |||
| W J Kowalski | |||
| T Mehlman | |||
| P2860 | cites work | Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria | Q29616614 |
| An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization | Q33979935 | ||
| Human vascular endothelial cells in culture. Growth and DNA synthesis | Q36196184 | ||
| Organizational behavior of human umbilical vein endothelial cells | Q36206496 | ||
| Bovine fibroblast growth factor: comparison of brain and pituitary preparations | Q36207046 | ||
| Purification and characterization of acidic fibroblast growth factor from bovine brain | Q36246754 | ||
| Mast cell heparin stimulates migration of capillary endothelial cells in vitro | Q36344096 | ||
| Isolation and partial molecular characterization of pituitary fibroblast growth factor | Q37565401 | ||
| Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor | Q37576712 | ||
| Factors involved in the modulation of cell proliferation in vivo and in vitro: The role of fibroblast and epidermal growth factors in the proliferative response of mammalian cells | Q37721239 | ||
| Growth factors in mammalian cell culture | Q40596973 | ||
| How to make a hybridoma. | Q41193348 | ||
| High and low molecular weight forms of endothelial cell growth factor | Q42825309 | ||
| Purification of a fibroblast growth factor from bovine pituitary | Q42833069 | ||
| Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain | Q48632706 | ||
| Long-term culture of human endothelial cells | Q48746057 | ||
| Purification, characterization, and biological properties of the eye-derived growth factor from retina: analogies with brain-derived growth factor | Q49033439 | ||
| Quantification of attached cells in microtiter plates based on Coomassie brilliant blue G-250 staining of total cellular protein. | Q50921259 | ||
| Angiogenesis in vitro | Q59054949 | ||
| Protamine is an inhibitor of angiogenesis | Q59075003 | ||
| A reevaluation of the response of human umbilical vein endothelial cells to certain growth factors | Q70180635 | ||
| Angiogenesis in vivo and selective mobilization of capillary endothelium in vitro by heparin-copper complex | Q70810400 | ||
| Human platelet-derived growth factor. Purification and resolution into two active protein fractions | Q70875540 | ||
| Human endothelial cells: use of heparin in cloning and long-term serial cultivation | Q71084423 | ||
| Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells | Q71431290 | ||
| Angiogenesis | Q72382806 | ||
| Polypeptide growth factors | Q72392118 | ||
| Liberation of Immunoreactive Somatomedin-C from Its Binding Proteins by Proteolytic Enzymes and Heparin* | Q72687058 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| antibody | Q79460 | ||
| cell growth | Q189159 | ||
| heparin | Q190016 | ||
| P304 | page(s) | 6138-6142 | |
| P577 | publication date | 1985-09-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Interaction of endothelial cell growth factor with heparin: characterization by receptor and antibody recognition | |
| P478 | volume | 82 |
| Q35818217 | A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane |
| Q34247367 | A novel protease obtained from FBS-containing culture supernatant, that processes single chain form hepatocyte growth factor to two chain form in serum-free culture |
| Q41643386 | A tyrosinated peptide representing the alternatively spliced exon of the platelet-derived growth factor A-chain binds specifically to cultured cells and interferes with binding of several growth factors |
| Q37485324 | Acidic and basic fibroblast growth factors are survival factors with distinctive activity in quiescent BALB/c 3T3 murine fibroblasts |
| Q35832256 | Acidic and basic fibroblast growth factors down-regulate collagen gene expression in keloid fibroblasts |
| Q42519290 | Acidic and basic fibroblast growth factors have comparable effects on the haemostatic function of vascular endothelium |
| Q67655961 | Acidic fibroblast growth factor (HBGF-1) stimulates DNA synthesis in primary rat hepatocyte cultures |
| Q67802293 | Acidic fibroblast growth factor autocrine system as a mediator of calcium-regulated parathyroid cell growth |
| Q42467568 | Acidic fibroblast growth factor overexpression in corneal epithelial wound healing |
| Q41341047 | An angiogenic growth factor is expressed in human glioma cells. |
| Q36697647 | Angiogenesis in the adult heart |
| Q36369670 | Characterization of a bovine acidic FGF cDNA clone and its expression in brain and retina |
| Q39605801 | Clinical applications of heparin-binding growth factors |
| Q33834836 | Cloned endothelial cells from fetal bovine bone |
| Q69826088 | Comparative endocrinology-paracrinology-autocrinology of human adult large vessel endothelial and smooth muscle cells |
| Q35898414 | Complex carbohydrates in drug development |
| Q35150877 | Control of Angiogenesis by Heparin and Other Sulfated Polysaccharides |
| Q44333243 | Culture of human corpus cavernosum endothelium |
| Q37216080 | Decreased type V collagen expression in human decidual tissues of spontaneous abortion during early pregnancy |
| Q41757013 | Disulfide Bonds are Neither Required, Present, Nor Compatible with Full Activity of Human Recombinant Acidic Fibroblast Growth Factor |
| Q40472425 | Drug-Induced Metabolic Bone Disease |
| Q41737473 | Effect of heparin on proliferation and signalling in BC3H-1 muscle cells. Evidence for specific binding sites |
| Q41147119 | Effect of heparin on pulmonary fibroblasts and vascular cells |
| Q35588456 | Effects of basic fibroblast growth factor on bone formation in vitro |
| Q34553837 | Effects of endothelial cell growth factor on bone remodelling in vitro |
| Q35856553 | Effects of growth factors in vivo. I. Cell ingrowth into porous subcutaneous chambers |
| Q39377428 | Endothelial cell growth factor (ECGF) application to irradiated soft tissue |
| Q42862465 | Endothelial cell growth factor and heparin regulate collagen gene expression in keloid fibroblasts |
| Q37484518 | Endothelial cell growth factor and ionophore A23187 stimulation of production of inositol phosphates in porcine aorta endothelial cells |
| Q34613112 | Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix |
| Q37558477 | Endothelial cells are activated by cytokine treatment to kill an intravascular parasite, Schistosoma mansoni, through the production of nitric oxide |
| Q54049715 | Engineering of an FGF-proteoglycan fusion protein with heparin-independent, mitogenic activity. |
| Q41091747 | Expression of acidic fibroblast growth factor cDNA confers growth advantage and tumorigenesis to Swiss 3T3 cells |
| Q39659653 | Extracellular matrices and polypeptide growth factors as mediators of functions of cells of the periodontium. A review |
| Q46448748 | Extracellular matrix of newly forming vessels—An immunohistochemical study |
| Q41026342 | FGF2-Heparin co-crystal complex-assisted design of mutants FGF1 and FGF7 with predictable heparin affinities |
| Q36385612 | Fibroblast (heparin-binding) growing factors in neuronal development and repair |
| Q67685247 | Fibronectin, not laminin, mediates heparin-dependent heparin-binding growth factor type I binding to substrata and stimulation of endothelial cell growth |
| Q40596119 | Growth factor-induced cell migration: biology and methods of analysis |
| Q38731894 | Growth factors and the skeletal system |
| Q41688239 | Heparin attenuates low-dose streptozotocin-induced immune diabetes in mice and inhibits the beta-cell binding of T-splenocytes in vitro |
| Q42550713 | Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling |
| Q41687946 | Heparin inhibits A431 cell growth independently of serum and EGF mitogenic signalling |
| Q41672364 | Heparin inhibits autocrine stimulation but not fibroblast growth factor stimulation of cell proliferation of androgen-responsive shionogi carcinoma 115 |
| Q54144863 | Heparin inhibits phorbol ester-induced ornithine decarboxylase gene expression in endothelial cells. |
| Q40546277 | Heparin lowers blood pressure: biological and clinical perspectives |
| Q36776434 | Heparin-binding growth factor 1 stimulates tyrosine phosphorylation in NIH 3T3 cells |
| Q42833313 | Heparin-binding growth factor-1 stimulation of human endothelial cells induces platelet-derived growth factor A-chain gene expression |
| Q41211116 | Heparin-binding growth factors and their receptors |
| Q41751554 | Heparin-mediated release of fibroblast growth factor-like activity into the circulation of rabbits |
| Q45185931 | High Affinity Receptors to Acidic and Basic Fibroblast Growth Factor (FGF) are Detected Mainly in Adult Brain Membrane Preparations but not in Liver, Kidney, Intestine, Lung or Stomach |
| Q36213936 | Human endothelial cells are chemotactic to endothelial cell growth factor and heparin |
| Q24634292 | Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor) |
| Q38335653 | Identification of heparan sulfate proteoglycan as a high affinity receptor for acidic fibroblast growth factor (aFGF) in a parathyroid cell line |
| Q37225389 | Increase in the relative level of type V collagen during development and ageing of the placenta |
| Q36216329 | Inhibition of endothelial cell proliferation by gamma-interferon |
| Q34572131 | Inhibition of human endothelial cell proliferation by gold compounds |
| Q34564068 | Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine |
| Q41432415 | Inositolhexakisphosphate (InsP6): an antagonist of fibroblast growth factor receptor binding and activity |
| Q42806229 | Investigation of the ability of several naturally occurring and synthetic polyanions to bind to and potentiate the biological activity of acidic fibroblast growth factor |
| Q42809736 | Long term growth factor exposure and differential tyrosine phosphorylation are required for DNA synthesis in BALB/c 3T3 cells |
| Q40403511 | Mast cells: accessory cells which potentiate fibrosis |
| Q36219208 | Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells |
| Q42807954 | Mitogenic activity of acidic fibroblast growth factor is enhanced by highly sulfated oligosaccharides derived from heparin and heparan sulfate |
| Q24563481 | Molecular cloning of PC3, a putatively secreted protein whose mRNA is induced by nerve growth factor and depolarization |
| Q43947297 | Monokines produced by macrophages stimulate the growth of osteoblasts |
| Q34235387 | Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor |
| Q36223338 | Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. |
| Q59204600 | Preparation and characterization of controlled heparin release waterborne polyurethane coating systems |
| Q41026319 | Preparation of a novel functional hydrogel consisting of sulfated glucoside-bearing polymer: activation of basic fibroblast growth factor |
| Q36792198 | Processing, secretion, and biological properties of a novel growth factor of the fibroblast growth factor family with oncogenic potential |
| Q43743987 | Production of Anti-Fibroblast Growth Factor Receptor Monoclonal Antibodies by In Vitro Immunization |
| Q35452819 | Proteoglycans in cell regulation |
| Q30194894 | Refinement of the structure of human basic fibroblast growth factor at 1.6 Å resolution and analysis of presumed heparin binding sites by selenate substitution |
| Q43664052 | Regulation of cell motility, morphology, and growth by sulfated glycosaminoglycans |
| Q70804076 | Stimulation of endothelial cell growth by myxalin |
| Q42798872 | Stimulation of polyphosphoinositide hydrolysis in Swiss 3T3 cells by recombinant fibroblast growth factors |
| Q55919452 | Structural and Functional Diversity in the FGf Receptor Multigene Family |
| Q36449477 | Structure and function of the heparin-binding (fibroblast) growth factor family |
| Q36713232 | Structure-Function Studies of Acidic Fibroblast Growth Factor |
| Q41881717 | Structure-function studies of heparin-binding (acidic fibroblast) growth factor-1 using site-directed mutagenesis |
| Q34467171 | The Fibroblast Growth Factor signaling pathway |
| Q33959703 | The acidic domain and first immunoglobulin-like loop of fibroblast growth factor receptor 2 modulate downstream signaling through glycosaminoglycan modification |
| Q34070358 | The adaptor CRADD/RAIDD controls activation of endothelial cells by proinflammatory stimuli |
| Q34559926 | The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression |
| Q74243165 | The effect of endothelial cell growth factor on peripheral nerve regeneration |
| Q70906115 | The effect of recombinant human basic fibroblast growth factor rhFGF-2 on human osteoblast in growth and phenotype expression |
| Q36433012 | The influence of heparin on the wound healing response to collagen implants in vivo. |
| Q73651827 | Therapeutic angiogenesis: a comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin |
| Q46211723 | Thomas Maciag: In praise of an open mind. |
| Q64318978 | Tissue Augmentation in Wound Healing: the Role of Endothelial and Epithelial Cells |
| Q40951648 | Vascular effects of sustained-release fibroblast growth factors |
| Q72085484 | aFGF Binding to Low and High Affinity Receptors Induces Both aFGF and aFGF Receptors Dimerization |
| Q67709845 | aFGF Content Increases with Malignancy in Human Chondrosarcoma and Bladder Cancer |
Search more.